Torthaí cuardaigh - Markus Luster

Beachtaigh na torthaí
  1. 1
    Dosimetry and thyroid cancer: the individual dosage of radioiodine

    Dosimetry and thyroid cancer: the individual dosage of radioiodine de réir Michael Laßmann, Christoph Reiners, Markus Luster

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Thyroid cancer in childhood: Management strategy, including dosimetry and long-term results

    Thyroid cancer in childhood: Management strategy, including dosimetry and long-term results de réir Markus Luster, Michael Laßmann, Lutz S. Freudenberg, Christoph Reiners

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases

    Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases de réir Frederik A. Verburg, Uwe Mäder, Markus Luster, Christoph Reiners

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Pediatric papillary thyroid cancer: current management challenges

    Pediatric papillary thyroid cancer: current management challenges de réir Frederik A. Verburg, Hanneke M. van Santen, Markus Luster

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma

    Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma de réir Heribert Hänscheid, Michael Laßmann, Markus Luster, Richard T. Kloos, Christoph Reiners

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Use of Recombinant Human Thyrotropin before Radioiodine Therapy in Patients with Advanced Differentiated Thyroid Carcinoma

    Use of Recombinant Human Thyrotropin before Radioiodine Therapy in Patients with Advanced Differentiated Thyroid Carcinoma de réir Markus Luster, Michael Laßmann, Heribert Haenscheid, U. Michalowski, C. Incerti, Christoph Reiners

    Foilsithe / Cruthaithe 2000
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Non-Surgical and Non-Radioiodine Techniques for Ablation of Benign Thyroid Nodules: Consensus Statement and Recommendation

    Non-Surgical and Non-Radioiodine Techniques for Ablation of Benign Thyroid Nodules: Consensus Statement and Recommendation de réir Joachim Feldkamp, F. Grünwald, Markus Luster, Kerstin Lorenz, Christian Vorländer, Dagmar Führer

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions

    Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions de réir Furio Pacini, Yasuhiro Ito, Markus Luster, Fabián Pitoia, Bruce Robinson, Lori J. Wirth

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Fine Needle Aspiration in the Investigation of Thyroid Nodules

    Fine Needle Aspiration in the Investigation of Thyroid Nodules de réir Joachim Feldkamp, Dagmar Führer, Markus Luster, Thomas J. Musholt, Christine Spitzweg, M. Schott

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review

    rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review de réir Markus Luster, Francesco Lippi, Barbara Jarząb, Petros Perros, Michael Laßmann, Christoph Reiners, Furio Pacini

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade

    Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade de réir Frederik A. Verburg, Glenn Flux, Luca Giovanella, Douglas Van Nostrand, Kristoff Muylle, Markus Luster

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Optimized Peptide Amount and Activity for <sup>90</sup>Y-Labeled DOTATATE Therapy

    Optimized Peptide Amount and Activity for <sup>90</sup>Y-Labeled DOTATATE Therapy de réir Peter Kletting, Thomas Kull, Christian Maaß, Noeen Malik, Markus Luster, Ambros J. Beer, Gerhard Glatting

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”

    Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray” de réir Boudewijn Brans, Lisa Bodei, Francesco Giammarile, O. Lindén, Markus Luster, Wim J.G. Oyen, Jan Tennvall

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Indications for the Surgical Management of Benign Goiter in Adults

    Indications for the Surgical Management of Benign Goiter in Adults de réir Detlef K. Bartsch, Markus Luster, H. J. Buhr, Dietmar Lorenz, Christoph‐Thomas Germer, Peter E. Goretzki

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Targeted therapy in nuclear medicine—current status and future prospects

    Targeted therapy in nuclear medicine—current status and future prospects de réir Wim J.G. Oyen, Lisa Bodei, Francesco Giammarile, Helmut R. Maëcke, Jan Tennvall, Markus Luster, Boudewijn Brans

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients ≥ 45 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and Normal in All Other DTC Patients

    Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients ≥ 45 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and... de réir Frederik A. Verburg, Uwe Mäder, Karina Tanase, E. Thies, Stefanie Dießl, Andreas K. Buck, Markus Luster, Christoph Reiners

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?

    2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? de réir Furio Pacini, Dagmar Führer, Rossella Elisei, Daria Handkiewicz-Junak, Sophie Leboulleux, Markus Luster, Martin Schlumberger, Johannes W. A. Smit

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy

    The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy de réir Scott A. Rivkees, Ernest L. Mazzaferri, Frederik A. Verburg, Christoph Reiners, Markus Luster, Christopher K. Breuer, Catherine Dinauer, Robert Udelsman

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Mutation-based, short-term “neoadjuvant” treatment allows resectability in stage IVB and C anaplastic thyroid cancer

    Mutation-based, short-term “neoadjuvant” treatment allows resectability in stage IVB and C anaplastic thyroid cancer de réir Elisabeth Maurer, Friederike Eilsberger, Sabine Wächter, Jorge Riera Knorrenschild, Anika Pehl, Katharina Holzer, Andreas Neubauer, Markus Luster, Detlef K. Bartsch

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Potency and Tolerance of Calcitonin Stimulation with High-Dose Calcium<i>Versus</i>Pentagastrin in Normal Adults

    Potency and Tolerance of Calcitonin Stimulation with High-Dose Calcium<i>Versus</i>Pentagastrin in Normal Adults de réir Pat Doyle, Christian Düren, Kai Nerlich, Frederik A. Verburg, I. Grelle, Hanne Jahn, Martin Faßnacht, Uwe Mäder, Christoph Reiners, Markus Luster

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: